ID AL3A1_HUMAN Reviewed; 453 AA. AC P30838; A8K828; Q9BT37; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 02-NOV-2010, sequence version 3. DT 27-MAR-2024, entry version 208. DE RecName: Full=Aldehyde dehydrogenase, dimeric NADP-preferring; DE EC=1.2.1.5 {ECO:0000269|PubMed:1737758, ECO:0000269|PubMed:22021038}; DE AltName: Full=ALDHIII; DE AltName: Full=Aldehyde dehydrogenase 3; DE AltName: Full=Aldehyde dehydrogenase family 3 member A1; GN Name=ALDH3A1; Synonyms=ALDH3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-134. RC TISSUE=Stomach; RA Schuuring E.M.D., Verhoeven E., Eckey R., Vos H.L., Michalides R.J.A.; RT "Cloning and complete nucleotide sequence of a cDNA encoding the full- RT length open reading frame of the human aldehyde dehydrogenase type III RT gene."; RL Submitted (AUG-1991) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY. RC TISSUE=Stomach; RX PubMed=1737758; DOI=10.1016/s0021-9258(19)50690-1; RA Hsu L.C., Chang W.-C., Shibuya A., Yoshida A.; RT "Human stomach aldehyde dehydrogenase cDNA and genomic cloning, primary RT structure, and expression in Escherichia coli."; RL J. Biol. Chem. 267:3030-3037(1992). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Stomach; RX PubMed=8493892; DOI=10.1007/978-1-4615-2904-0_16; RA Hsu L.C., Yoshida A.; RT "Human stomach aldehyde dehydrogenase, ALDH3."; RL Adv. Exp. Med. Biol. 328:141-152(1993). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-134. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-134. RC TISSUE=Cervix, and Tongue; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16625196; DOI=10.1038/nature04689; RA Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., RA Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., RA Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., RA Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J., RA DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S., RA Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E., RA Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K., RA LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J., RA Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A., RA Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., RA Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D., RA Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A., RA Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.; RT "DNA sequence of human chromosome 17 and analysis of rearrangement in the RT human lineage."; RL Nature 440:1045-1049(2006). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-134. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-134. RC TISSUE=Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [9] RP PROTEIN SEQUENCE OF 62-453. RC TISSUE=Stomach; RX PubMed=2037078; DOI=10.1016/0014-5793(91)80559-l; RA Yin S.-J., Vagelopoulos N., Wang S.-L., Joernvall H.; RT "Structural features of stomach aldehyde dehydrogenase distinguish dimeric RT aldehyde dehydrogenase as a 'variable' enzyme. 'Variable' and 'constant' RT enzymes within the alcohol and aldehyde dehydrogenase families."; RL FEBS Lett. 283:85-88(1991). RN [10] RP CHARACTERIZATION. RX PubMed=1905102; DOI=10.1007/978-1-4684-5901-2_6; RA Eckey R., Timmann R., Hempel J., Agarwal D.P., Goedde H.W.; RT "Biochemical, immunological, and molecular characterization of a 'high Km' RT aldehyde dehydrogenase."; RL Adv. Exp. Med. Biol. 284:43-52(1991). RN [11] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-178 AND LYS-194, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., RA Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [12] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [13] RP ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). RN [14] RP X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) IN COMPLEX WITH INHIBITOR, CATALYTIC RP ACTIVITY, MUTAGENESIS OF CYS-244, AND ACTIVE SITE. RX PubMed=22021038; DOI=10.1074/jbc.m111.293597; RA Khanna M., Chen C.H., Kimble-Hill A., Parajuli B., Perez-Miller S., RA Baskaran S., Kim J., Dria K., Vasiliou V., Mochly-Rosen D., Hurley T.D.; RT "Discovery of a novel class of covalent inhibitor for aldehyde RT dehydrogenases."; RL J. Biol. Chem. 286:43486-43494(2011). RN [15] RP VARIANT ALA-329. RX PubMed=9250352; DOI=10.1046/j.1469-1809.1997.6130235.x; RA Tsukamoto N., Chang C., Yoshida A.; RT "Mutations associated with Sjogren-Larsson syndrome."; RL Ann. Hum. Genet. 61:235-242(1997). CC -!- FUNCTION: ALDHs play a major role in the detoxification of alcohol- CC derived acetaldehyde (Probable). They are involved in the metabolism of CC corticosteroids, biogenic amines, neurotransmitters, and lipid CC peroxidation (Probable). Oxidizes medium and long chain aldehydes into CC non-toxic fatty acids (PubMed:1737758). Preferentially oxidizes CC aromatic aldehyde substrates (PubMed:1737758). Comprises about 50 CC percent of corneal epithelial soluble proteins (By similarity). May CC play a role in preventing corneal damage caused by ultraviolet light CC (By similarity). {ECO:0000250|UniProtKB:P47739, CC ECO:0000269|PubMed:1737758, ECO:0000305}. CC -!- CATALYTIC ACTIVITY: CC Reaction=an aldehyde + H2O + NAD(+) = a carboxylate + 2 H(+) + NADH; CC Xref=Rhea:RHEA:16185, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17478, ChEBI:CHEBI:29067, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:57945; EC=1.2.1.5; Evidence={ECO:0000269|PubMed:1737758, CC ECO:0000269|PubMed:22021038}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + NAD(+) + octanal = 2 H(+) + NADH + octanoate; CC Xref=Rhea:RHEA:44100, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17935, ChEBI:CHEBI:25646, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:57945; Evidence={ECO:0000250|UniProtKB:P47739}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC Note=Has a high Km for acetaldehyde.; CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:22021038}. CC -!- INTERACTION: CC P30838; O75344: FKBP6; NbExp=3; IntAct=EBI-3905126, EBI-744771; CC P30838; Q9NUX5: POT1; NbExp=2; IntAct=EBI-3905126, EBI-752420; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P47739}. CC -!- TISSUE SPECIFICITY: High levels in stomach, esophagus and lung; low CC level in the liver and kidney. CC -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M74542; AAA51696.1; -; mRNA. DR EMBL; M77477; AAB46377.1; -; mRNA. DR EMBL; S61044; AAB26658.1; -; mRNA. DR EMBL; BT007102; AAP35766.1; -; mRNA. DR EMBL; AK292193; BAF84882.1; -; mRNA. DR EMBL; AK314584; BAG37160.1; -; mRNA. DR EMBL; AC005722; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471212; EAW50909.1; -; Genomic_DNA. DR EMBL; BC004370; AAH04370.1; -; mRNA. DR EMBL; BC008892; AAH08892.1; -; mRNA. DR EMBL; BC021194; AAH21194.1; -; mRNA. DR CCDS; CCDS11212.1; -. DR PIR; A42584; A42584. DR RefSeq; NP_000682.3; NM_000691.4. DR RefSeq; NP_001128639.1; NM_001135167.1. DR RefSeq; NP_001128640.1; NM_001135168.1. DR PDB; 3SZA; X-ray; 1.48 A; A/B=1-453. DR PDB; 3SZB; X-ray; 1.51 A; A/B=1-453. DR PDB; 4H80; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-453. DR PDB; 4L1O; X-ray; 2.30 A; A/B=1-453. DR PDB; 4L2O; X-ray; 1.94 A; A/B/E/G=1-453. DR PDB; 8BB8; X-ray; 1.80 A; A/B=2-453. DR PDBsum; 3SZA; -. DR PDBsum; 3SZB; -. DR PDBsum; 4H80; -. DR PDBsum; 4L1O; -. DR PDBsum; 4L2O; -. DR PDBsum; 8BB8; -. DR AlphaFoldDB; P30838; -. DR SMR; P30838; -. DR BioGRID; 106720; 93. DR IntAct; P30838; 16. DR STRING; 9606.ENSP00000411821; -. DR BindingDB; P30838; -. DR ChEMBL; CHEMBL3578; -. DR DrugBank; DB00157; NADH. DR GlyGen; P30838; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P30838; -. DR PhosphoSitePlus; P30838; -. DR SwissPalm; P30838; -. DR BioMuta; ALDH3A1; -. DR DMDM; 311033473; -. DR EPD; P30838; -. DR jPOST; P30838; -. DR MassIVE; P30838; -. DR MaxQB; P30838; -. DR PaxDb; 9606-ENSP00000411821; -. DR PeptideAtlas; P30838; -. DR PRIDE; P30838; -. DR ProteomicsDB; 54741; -. DR Pumba; P30838; -. DR Antibodypedia; 26030; 522 antibodies from 40 providers. DR DNASU; 218; -. DR Ensembl; ENST00000225740.11; ENSP00000225740.6; ENSG00000108602.18. DR Ensembl; ENST00000444455.5; ENSP00000388469.1; ENSG00000108602.18. DR Ensembl; ENST00000457500.6; ENSP00000411821.2; ENSG00000108602.18. DR GeneID; 218; -. DR KEGG; hsa:218; -. DR MANE-Select; ENST00000225740.11; ENSP00000225740.6; NM_000691.5; NP_000682.3. DR UCSC; uc002gwj.4; human. DR AGR; HGNC:405; -. DR CTD; 218; -. DR DisGeNET; 218; -. DR GeneCards; ALDH3A1; -. DR HGNC; HGNC:405; ALDH3A1. DR HPA; ENSG00000108602; Tissue enhanced (esophagus, salivary gland, stomach). DR MIM; 100660; gene. DR neXtProt; NX_P30838; -. DR OpenTargets; ENSG00000108602; -. DR PharmGKB; PA24697; -. DR VEuPathDB; HostDB:ENSG00000108602; -. DR eggNOG; KOG2456; Eukaryota. DR GeneTree; ENSGT00940000162101; -. DR InParanoid; P30838; -. DR OMA; EPCIQGQ; -. DR OrthoDB; 606537at2759; -. DR PhylomeDB; P30838; -. DR TreeFam; TF314264; -. DR BRENDA; 1.2.1.5; 2681. DR PathwayCommons; P30838; -. DR Reactome; R-HSA-211945; Phase I - Functionalization of compounds. DR SABIO-RK; P30838; -. DR SignaLink; P30838; -. DR SIGNOR; P30838; -. DR BioGRID-ORCS; 218; 15 hits in 1156 CRISPR screens. DR ChiTaRS; ALDH3A1; human. DR EvolutionaryTrace; P30838; -. DR GeneWiki; Aldehyde_dehydrogenase_3_family,_member_A1; -. DR GenomeRNAi; 218; -. DR Pharos; P30838; Tchem. DR PRO; PR:P30838; -. DR Proteomes; UP000005640; Chromosome 17. DR RNAct; P30838; Protein. DR Bgee; ENSG00000108602; Expressed in nasal cavity epithelium and 151 other cell types or tissues. DR ExpressionAtlas; P30838; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb. DR GO; GO:0005615; C:extracellular space; HDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:HPA. DR GO; GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; IBA:GO_Central. DR GO; GO:0008106; F:alcohol dehydrogenase (NADP+) activity; IDA:UniProtKB. DR GO; GO:0004029; F:aldehyde dehydrogenase (NAD+) activity; IDA:UniProtKB. DR GO; GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; TAS:Reactome. DR GO; GO:0018479; F:benzaldehyde dehydrogenase (NAD+) activity; IDA:CACAO. DR GO; GO:0006081; P:cellular aldehyde metabolic process; IDA:UniProtKB. DR GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW. DR GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome. DR CDD; cd07132; ALDH_F3AB; 1. DR InterPro; IPR016161; Ald_DH/histidinol_DH. DR InterPro; IPR016163; Ald_DH_C. DR InterPro; IPR016160; Ald_DH_CS_CYS. DR InterPro; IPR029510; Ald_DH_CS_GLU. DR InterPro; IPR016162; Ald_DH_N. DR InterPro; IPR015590; Aldehyde_DH_dom. DR InterPro; IPR012394; Aldehyde_DH_NAD(P). DR PANTHER; PTHR43570; ALDEHYDE DEHYDROGENASE; 1. DR PANTHER; PTHR43570:SF15; ALDEHYDE DEHYDROGENASE, DIMERIC NADP-PREFERRING; 1. DR Pfam; PF00171; Aldedh; 1. DR PIRSF; PIRSF036492; ALDH; 1. DR SUPFAM; SSF53720; ALDH-like; 1. DR PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1. DR PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1. DR Genevisible; P30838; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; KW Lipid metabolism; NAD; NADP; Oxidoreductase; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:22814378" FT CHAIN 2..453 FT /note="Aldehyde dehydrogenase, dimeric NADP-preferring" FT /id="PRO_0000056470" FT ACT_SITE 210 FT /evidence="ECO:0000269|PubMed:22021038" FT ACT_SITE 244 FT /evidence="ECO:0000269|PubMed:22021038" FT BINDING 188..193 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000250" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0007744|PubMed:22814378" FT MOD_RES 178 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT MOD_RES 194 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT VARIANT 134 FT /note="S -> A (in dbSNP:rs887241)" FT /evidence="ECO:0000269|PubMed:14702039, FT ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1, FT ECO:0000269|Ref.4, ECO:0000269|Ref.7" FT /id="VAR_018981" FT VARIANT 309 FT /note="G -> E (in dbSNP:rs3744692)" FT /id="VAR_018982" FT VARIANT 329 FT /note="P -> A (in allele ALDH3A1*2; dbSNP:rs2228100)" FT /evidence="ECO:0000269|PubMed:9250352" FT /id="VAR_011303" FT MUTAGEN 244 FT /note="C->S: Abolishes activity." FT /evidence="ECO:0000269|PubMed:22021038" FT CONFLICT 12 FT /note="R -> P (in Ref. 2; AAB46377 and 3; AAB26658)" FT /evidence="ECO:0000305" FT CONFLICT 27 FT /note="I -> F (in Ref. 1; AAA51696)" FT /evidence="ECO:0000305" FT CONFLICT 170 FT /note="V -> L (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 436 FT /note="D -> E (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 3..16 FT /evidence="ECO:0007829|PDB:3SZA" FT TURN 17..20 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 23..39 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 41..52 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 56..61 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 64..82 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 91..93 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 96..104 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 106..111 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 114..116 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 119..130 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 134..138 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 141..143 FT /evidence="ECO:0007829|PDB:4L2O" FT HELIX 144..157 FT /evidence="ECO:0007829|PDB:3SZA" FT TURN 160..162 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 170..176 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 182..188 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 190..201 FT /evidence="ECO:0007829|PDB:3SZA" FT TURN 202..204 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 207..210 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 216..219 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 225..237 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 238..241 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 249..252 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 254..256 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 257..272 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 276..278 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 288..298 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 301..305 FT /evidence="ECO:0007829|PDB:3SZA" FT TURN 311..314 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 319..323 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 329..331 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 337..344 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 348..357 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 362..367 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 371..380 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 384..389 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 393..395 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 406..408 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 416..421 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 423..430 FT /evidence="ECO:0007829|PDB:3SZA" FT HELIX 437..442 FT /evidence="ECO:0007829|PDB:3SZA" FT STRAND 443..445 FT /evidence="ECO:0007829|PDB:3SZA" SQ SEQUENCE 453 AA; 50395 MW; D35C488A022FAACA CRC64; MSKISEAVKR ARAAFSSGRT RPLQFRIQQL EALQRLIQEQ EQELVGALAA DLHKNEWNAY YEEVVYVLEE IEYMIQKLPE WAADEPVEKT PQTQQDELYI HSEPLGVVLV IGTWNYPFNL TIQPMVGAIA AGNSVVLKPS ELSENMASLL ATIIPQYLDK DLYPVINGGV PETTELLKER FDHILYTGST GVGKIIMTAA AKHLTPVTLE LGGKSPCYVD KNCDLDVACR RIAWGKFMNS GQTCVAPDYI LCDPSIQNQI VEKLKKSLKE FYGEDAKKSR DYGRIISARH FQRVMGLIEG QKVAYGGTGD AATRYIAPTI LTDVDPQSPV MQEEIFGPVL PIVCVRSLEE AIQFINQREK PLALYMFSSN DKVIKKMIAE TSSGGVAAND VIVHITLHSL PFGGVGNSGM GSYHGKKSFE TFSHRRSCLV RPLMNDEGLK VRYPPSPAKM TQH //